Trusted Business Insights presents the Latest Study on Molecular Cytogenetics Market 2019-2025. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.
Get Sample Copy of this Report @ Molecular Cytogenetics Market Size, Share, Sector / Industry Report & Analysis, 2018-2025
Abstract, Snapshot, Market Analysis & Market Definition: Global Molecular Cytogenetics Market
The global molecular cytogenetics market size was estimated at USD 1.5 billion in 2016. Cytogenetic analysis was earlier limited to investigation of cellular aspects that covered detection of genomic aberrations and study of chromosomal structure in heredity conditions. In the current scenario, cytogenetic analysis goes beyond simple investigation of chromosomal status of genome. This has accelerated the study of chromosomal changes that are involved in disease pathogenesis, three-dimensional organization of the human genome, and nature of inherited syndromes.
Currently, the most important goal of human genetics is to bridge the gap between clinical applications of genetic findings and accordingly provide a refined medical service. Growth in utilization of genetic information in predictive models for disease traits has a direct impact on adoption of cytogenetic tools, thereby boosting revenue generation.
Increasing incidence of cancer and related growth in mortality per year has significantly driven the market. Continued rise in new cancer cases has emphasized the need for development of advanced technologies for a comprehensive understanding of cancer at a genomic level.
FISH and Comparative Genomic Hybridization (CGH) are among the most recognized cytogenetic techniques as they provide thorough information about cancer-related molecular signatures. These methods aid in gaining insights on cancer progression.
Growing activities in pharmacogenomics are anticipated to significantly impact market growth as several cytogenetic tools have been successfully used for pharmacogenomic biomarker studies. Effective use of CGH, FISH, and sequencing technology in pharmacogenomics is evident by the presence of a substantial number of published articles demonstrating the role of cytogenetic techniques in pharmacogenomic testing.
Ongoing technological advancements in CGH and FISH, with respect to resolution and specificity, have augmented the application scope of cytogenetics tools in basic research and molecular diagnostics. These advancements have successfully overcome the limitations of conventional cytogenetic analysis.
Lack of predictable coverage and reimbursement policies for new genomic tools could hinder the application of molecular cytogenetics in cancer and personalized care. Moreover, dearth of skilled personnel and high expense associated with maintenance and handling of advanced techniques are expected to impede the market in future.
Market Segmentation, Outlook & Viewpoint: Global Molecular Cytogenetics Market
Application Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Product Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Software & Services
End-use Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Clinical & Research Laboratories
Hospitals & Pathology Laboratories
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Comparative Genomic Hybridization
Array-based comparative genomic hybridization
Standard comparative genomic hybridization
Fluorescence In Situ Hybridization (FISH)
Key Players, Recent Developments & Regional Insights: Global Molecular Cytogenetics Market
Are you working or have business association with any of the below-listed market leaders? If Yes, Request any ONE of your Competitor Data for free here. *T&C Apply*
The molecular cytogenetics market offers a broad range of products, such as instruments/equipment, consumables, and software and services. Advances in molecular biology techniques have also propelled the development of associated consumables, reagents, kits, and software.
Rising usage of media and reagents while performing cytogenetic analysis has rendered consumables as the largest segment. Consumables assist in gaining accurate and reproducible results in standard as well as advanced clinical cytogenetic protocols.
However, in the coming years, software and services are expected to serve as a lucrative source of revenue owing to ongoing development in solutions and algorithms to manage and interpret massive amounts of genomic data.
Ongoing genomic research activities have resulted in surplus volumes of genomic findings. This, in turn, has propelled companies to invest in the development of robust and sophisticated software and algorithms to simplify cytogenetic analysis.
Clinical and research laboratories dominated the market in 2016. This is majorly due to growing implementation of cytogenetic techniques in clinical diagnosis. Ongoing research pertaining to pathways underlying various chromosomal diseases has enabled this segment to attain the largest share.
With growing demand for targeted therapies, the implementation of molecular cytogenetics in pharmaceutical and biotech companies is expected to grow at a lucrative pace. The popular trend of companion diagnostics is also expected to support the growth of this segment throughout the forecast period.
Availability, turnaround time, cost, and specificity are key factors that play a significant role in the adoption of cytogenetic techniques. In the current scenario, CGH and FISH techniques are widely adopted across various applications such as diagnostics, research activities, and medicine development.
The many advantages CGH and FISH techniques offer over conventional techniques have allowed these segments to account for a major share in the market. CGH captured the dominant share owing to its vital role in comprehensive cancer studies. High resolution offered by array-based CGH has also contributed to its growth. Array-based CGH has significantly addressed the limitations of standard CGH with respect to labor requirement and resolution. This technique has also eliminated the need for metaphase chromosomes, which results in enhanced resolution.
North America accounted for the largest share in 2016 mainly due to the local presence of major entities, such as Agilent Technologies, Inc. Moreover, presence of effective regulatory framework for the regulation of genetic tests has significantly propelled the regional market.
Asia Pacific is expected to emerge as the fastest growing regional market during the course of the forecast period. Continuous GDP growth of countries such as China and India is anticipated to enhance consumer buying power and drive regional growth. Ongoing workshops and interventions in Asia Pacific pertaining to current trends and developments in human genetics and disease management are driving the Asian market. These workshops are aimed at improving awareness about the significance of advanced diagnostics and therapies among the population.
Molecular Cytogenetics Market Share Insights
BIOVIEW; Danaher; MetaSystems; Agilent Technologies, Inc.; Abbott; Bio-Rad Laboratories, Inc.; Illumina, Inc.; Oxford Gene Technology; F. Hoffmann-La Roche Ltd.; PerkinElmer Inc.; Quest Diagnostics Incorporated; Applied Spectral Imaging; Biological Industries USA, Inc.; CytoTest; Cytognomix; Genial Genetics; and Diagnostic Cytogenetics, Inc. (DCI) are some of the prominent players operating in the market. These players are engaged in manufacturing and marketing of cytogenetic tests and techniques for service providers.
Understanding the growing demand for cytogenetic analysis amongst the population, manufacturers are making significant investments to broaden their product portfolio. They are also engaging in mutually beneficial partnerships with laboratories and research institutes, which in turn, boosts revenue generation for these companies.
Some service providers that offer cytogenetic technique-based services are Weill Cornell Medicine; UCLA Health – UCLA Pathology and Laboratory Medicines; OHSU School of Medicine-Molecular and Medical Genetics; Integrated Systems Engineering S.r.l.; WiCell Research Institute, Inc.; Virtual Scientific; UW Cytogenetic Services; Genesis Laboratories Inc.; Calgary Laboratory Services; Neogenomics; ARUP Laboratories; and South West Thames Regional Genetics Service.
Key Insights Covered: Global Molecular Cytogenetics Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Molecular Cytogenetics industry.
2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Molecular Cytogenetics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Molecular Cytogenetics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Molecular Cytogenetics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Molecular Cytogenetics industry.
Research Methodology: Global Molecular Cytogenetics Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Quick Read Table of Contents of this Report @ Molecular Cytogenetics Market Size, Share, Sector / Industry Report & Analysis, 2018-2025
Trusted Business Insights
Media & Marketing Executive
Email Me For Any Clarifications
US: +1 646 568 9797
UK: +44 330 808 0580
This post was originally published on Analytics News